Insidersinvested$26.5mI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyI'm ashareholdermyselfHemorrhoidsis a $2BmarketOur Halo-Lido trial willhave finalpatient byend of 2022We willhaveexclusivityMino-Lokpotentialmarket>$1BThere are noFDAapproveddrugs to treathemorrhoidsI won't diluteshareholdersWe intendto submita BLA in2H 2022We expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Mino-WrapAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We will openupinternationalsites forMino-Lok trialOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyI'm ashareholdermyselfHemorrhoidsis a $2BmarketOur Halo-Lido trial willhave finalpatient byend of 2022We willhaveexclusivityMino-Lokpotentialmarket>$1BThere are noFDAapproveddrugs to treathemorrhoidsI won't diluteshareholdersWe intendto submita BLA in2H 2022We expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Mino-WrapAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We will openupinternationalsites forMino-Lok trialOnly biotechwith 2 Myron'son theleadershipteam

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Insiders invested $26.5m
  2. I/ONTAK was the best deal I ever made
  3. Mino-Lok is our lead asset
  4. Not many companies this size with 2 late stage assets
  5. We have enough cash to go well into 2023
  6. I/ONTAK is our lead asset
  7. We had a phase 2b trial with 100% efficacy
  8. I'm a shareholder myself
  9. Hemorrhoids is a $2B market
  10. Our Halo-Lido trial will have final patient by end of 2022
  11. We will have exclusivity
  12. Mino-Lok potential market >$1B
  13. There are no FDA approved drugs to treat hemorrhoids
  14. I won't dilute shareholders
  15. We intend to submit a BLA in 2H 2022
  16. We expect to finish the Mino-Lok trial this year
  17. Myron Holubiak and I founded a private company in 2013
  18. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  19. Mino-Wrap
  20. An actual iMSC update
  21. I/ONTAK's potential market is >$300m
  22. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  23. We will open up international sites for Mino-Lok trial
  24. Only biotech with 2 Myron's on the leadership team